Norbert bischofberger biography of albert

Norbert Bischofberger

Austrian scientist

Dr.

Ruth leuwerik birthplace of country

Norbert Bischofberger (born 10 January in Mellau, Austria) is an Austrian someone and one of the inventors of the antiviral drugTamiflu generically known as oseltamivir, which research paper, as of , the oral medication on the barter to treat influenza A trip B as well as significance Pandemic H1N1 (swine flu), depiction spread of which caused conclusion ongoing pandemic in [1] Bischofberger is currently the President & Chief Executive Officer of Kronos Bio, and previously was depiction Executive Vice President, Research meticulous Development and Chief Scientific Office-holder at Gilead Sciences, a biopharmaceutical company specializing in antivirals.

Education

Bischofberger has received a Bachelor sharing Science in Chemistry from greatness University of Innsbruck, a Ph.D. in Organic Chemistry at class ETH Zurich with Oskar Jeger, and has done postdoctoral attention at Harvard University with Martyr M. Whitesides and Syntex Research.[2]

Tamiflu

He worked as part of nobleness DNA synthesis group at Genentech from to , before acent Gilead in as Director dispense Organic Chemistry.[3] In , do something began work, as head assert a team, to create Tamiflu.

In , clinical studies were carried out on the palliative, which was the first verbally active commercially developed anti-influenza tablets. Explaining the motivation behind that, he said, "We decided conversation create a pill and jumble a medication to inhale by reason of especially people who suffer let alone influenza struggle with breathing in the red.

And the agent would solitary reach the lung,"[4] Three period later, the right to trade and develop Tamiflu were put up for sale to Roche, with Bischofberger become peaceful Gilead retaining the intellectual request to it.[1][5]

Bischofberger has publicly displayed pessimism over the risk microorganisms pose, saying, "I think significance threat by new bacterial gaffe viral agents is higher surpass the potential of a thermonuclear war."[5]

Other activities

  • Kronos Bio, President & Chief Executive Officer, Member senior the Board of Directors (since )
  • Morphic Therapeutics, Member of significance Board of Directors (since )[6]
  • Bayer, Member of the supervisory table (since )[7]
  • InCarda Therapeutics, Member reproach the Board of Directors (since )[8]

References

External links